Day & Ennis’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $436K | Hold |
8,505
| – | – | 0.15% | 81 |
|
|
2023
Q3 | $494K | Hold |
8,505
| – | – | 0.18% | 77 |
|
|
2023
Q2 | $544K | Hold |
8,505
| – | – | 0.21% | 72 |
|
|
2023
Q1 | $589K | Hold |
8,505
| – | – | 0.22% | 68 |
|
|
2022
Q4 | $612K | Hold |
8,505
| – | – | 0.24% | 68 |
|
|
2022
Q3 | $605K | Hold |
8,505
| – | – | 0.25% | 62 |
|
|
2022
Q2 | $655K | Hold |
8,505
| – | – | 0.25% | 63 |
|
|
2022
Q1 | $621K | Hold |
8,505
| – | – | 0.21% | 64 |
|
|
2021
Q4 | $530K | Hold |
8,505
| – | – | 0.17% | 72 |
|
|
2021
Q3 | $503K | Hold |
8,505
| – | – | 0.17% | 73 |
|
|
2021
Q2 | $568K | Hold |
8,505
| – | – | 0.2% | 65 |
|
|
2021
Q1 | $537K | Hold |
8,505
| – | – | 0.2% | 67 |
|
|
2020
Q4 | $528K | Hold |
8,505
| – | – | 0.21% | 62 |
|
|
2020
Q3 | $513K | Hold |
8,505
| – | – | 0.22% | 62 |
|
|
2020
Q2 | $500K | Hold |
8,505
| – | – | 0.25% | 60 |
|
|
2020
Q1 | $474K | Buy |
8,505
+136
| +2% | +$8.31K | 0.27% | 55 |
|
|
2019
Q4 | $537K | Buy |
8,369
+53
| +0.6% | +$3.04K | 0.26% | 56 |
|
|
2019
Q3 | $422K | Hold |
8,316
| – | – | 0.22% | 62 |
|
|
2019
Q2 | $377K | Buy |
8,316
+2,000
| +32% | +$93.2K | 0.2% | 62 |
|
|
2019
Q1 | $301K | Sell |
6,316
-40
| -0.6% | -$1.99K | 0.17% | 61 |
|
|
2018
Q4 | $330K | Hold |
6,356
| – | – | 0.22% | 62 |
|
|
2018
Q3 | $395K | Hold |
6,356
| – | – | 0.27% | 57 |
|
|
2018
Q2 | $352K | Buy |
6,356
+11
| +0.2% | +$594 | 0.26% | 62 |
|
|
2018
Q1 | $401K | Hold |
6,345
| – | – | 0.33% | 52 |
|
|
2017
Q4 | $389K | Hold |
6,345
| – | – | 0.32% | 53 |
|
|
2017
Q3 | $404K | Sell |
6,345
-2,945
| -32% | -$172K | 0.36% | 47 |
|
|
2017
Q2 | $518K | Hold |
9,290
| – | – | 0.45% | 44 |
|
|
2017
Q1 | $505K | Sell |
9,290
-1,505
| -14% | -$82.5K | 0.48% | 37 |
|
|
2016
Q4 | $631K | Hold |
10,795
| – | – | 0.65% | 30 |
|
|
2016
Q3 | $582K | Hold |
10,795
| – | – | 0.61% | 30 |
|
|
2016
Q2 | $794K | Hold |
10,795
| – | – | 0.86% | 26 |
|
|
2016
Q1 | $690K | Hold |
10,795
| – | – | 0.76% | 26 |
|
|
2015
Q4 | $743K | Buy |
+10,795
| New | +$713K | 0.83% | 26 |
|
Other funds holding BMY
Day & Ennis's BMY Position: Q4 2023 in Review
Day & Ennis held its Bristol-Myers Squibb (BMY) position steady in Q4 2023 at 8,505 shares worth $436K. The position accounts for 0.15% of the portfolio, ranked #81.
Day & Ennis first reported a position in BMY in Q4 2015 and has held it in 33 quarters since. The position peaked at $794K in Q2 2016. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.
- Day & Ennis held 8,505 shares of Bristol-Myers Squibb worth $436K as of Q4 2023.
- Day & Ennis left its Bristol-Myers Squibb share count unchanged in Q4 2023.
- Bristol-Myers Squibb made up 0.15% of Day & Ennis's portfolio in Q4 2023, its #81 holding.
- Day & Ennis first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 33 quarters since.
- Day & Ennis's Bristol-Myers Squibb position peaked at $794K in Q2 2016.
- 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.
Based on Day & Ennis's 13F filing for Q4 2023, filed 18 Jan 2024.